Cargando…

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease

Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.

Detalles Bibliográficos
Autores principales:	Talman, Sander, Uzun, Sevim, Djamin, Remco S, Baart, Sara J, Grootenboers, Marco J J H, Aerts, Joachim, van der Eerden, Menno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935328/ https://www.ncbi.nlm.nih.gov/pubmed/33688175 http://dx.doi.org/10.2147/COPD.S284397

Ejemplares similares

Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
por: Djamin, Remco S., et al.
Publicado: (2020)

Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): Study protocol for a randomised controlled trial
por: Uzun, Sevim, et al.
Publicado: (2012)

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial
por: Chalmers, James D., et al.
Publicado: (2018)

Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations
por: Cuevas, Ester, et al.
Publicado: (2023)

Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

Endoscopic Ultrasound Fine Needle Aspiration in the Diagnosis of Lymphoma
por: Creemers, Koen, et al.
Publicado: (2011)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
por: Wedzicha, Jadwiga A, et al.
Publicado: (2013)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease
por: Yang, Chengyu, et al.
Publicado: (2023)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

Azithromycin: Exacerbation of diaphragm hemiparesis: case report
Publicado: (2020)

Azithromycin buccal patch in treatment of chronic periodontitis
por: Latif, Sajith Abdul, et al.
Publicado: (2016)

Spectrophotometric Estimation of Azithromycin in Tablets
por: Jayanna, B. K., et al.
Publicado: (2012)

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
por: Hasegawa, Kohei, et al.
Publicado: (2014)

Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
por: McCullagh, Brian N., et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
por: Uslu, Berat, et al.
Publicado: (2022)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
por: Charriot, Jeremy, et al.
Publicado: (2023)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Relationship between Periodontitis-Related Antibody and Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Takahashi, Tamaki, et al.
Publicado: (2012)

Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease
por: Chang, Chun, et al.
Publicado: (2014)

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Su, Linfan, et al.
Publicado: (2022)

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
por: Singh, Dave, et al.
Publicado: (2023)

Azithromycin: The Holy Grail to Prevent Exacerbations in Chronic Respiratory Disease?
por: Welte, Tobias
Publicado: (2019)

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease
por: Tomioka, Ryusuke, et al.
Publicado: (2016)

A search for covert precipitating clinical parameters in frequent exacerbators of chronic obstructive pulmonary disease
por: Bhatia, Ankit, et al.
Publicado: (2016)

Improvements in azithromycin recrystallization using ultrasound for size reduction
por: Sabnis, Sarvesh S., et al.
Publicado: (2022)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
por: Albanji, Muradi, et al.
Publicado: (2022)

Clinical and pulmonary functions profiling of patients with chronic obstructive pulmonary disease experiencing frequent acute exacerbations
por: Gupta, Prem Parkash, et al.
Publicado: (2018)

Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora
por: Ke, Li, et al.
Publicado: (2022)

The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population
por: Liu, Dan, et al.
Publicado: (2023)

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
por: Pomares, Xavier, et al.
Publicado: (2011)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022)

Azithromycin-Induced Liver Injury in an Asthma Exacerbation Patient With Autoimmune Features
por: Liang, Richard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uv9j333e2fquom8q1di7j48p0h